La Jolla Pharmaceutical Company (LJPC) Announces Quarterly Earnings Results
La Jolla Pharmaceutical Company (NASDAQ:LJPC) announced its earnings results on Thursday. The company reported ($0.63) earnings per share (EPS) for the quarter, StockRatingsNetwork reports.
La Jolla Pharmaceutical Company (NASDAQ:LJPC) traded up 1.61% on Thursday, hitting $10.07. The stock had a trading volume of 89,292 shares. La Jolla Pharmaceutical Company has a 52 week low of $0.16 and a 52 week high of $19.50. The stock’s 50-day moving average is $10.05 and its 200-day moving average is $9.56. The company’s market cap is $79.2 million.
A number of analysts have recently weighed in on LJPC shares. Analysts at Jefferies Group initiated coverage on shares of La Jolla Pharmaceutical Company in a research note on Monday, August 4th. They set a “buy” rating and a $25.00 price target on the stock. On the ratings front, analysts at Wedbush reiterated a “buy” rating on shares of La Jolla Pharmaceutical Company in a research note on Tuesday, July 15th. Finally, analysts at Noble Financial raised their price target on shares of La Jolla Pharmaceutical Company from $34.00 to $38.00 in a research note on Wednesday, July 9th. They now have a “buy” rating on the stock. Six research analysts have rated the stock with a buy rating, La Jolla Pharmaceutical Company has an average rating of “Buy” and an average target price of $30.20.
La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the development of therapeutic agents that inhibit the activity of galectins as a means of treating human diseases such as chronic organ failure and cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.